
|Articles|June 24, 2004
CMS, NCI to prioritize cancer research, improve drug approval process
The Centers for Medicare & Medicaid Services and the National Cancer Institute have developed a joint Memorandum of Understanding to address how the two agencies can work together in five areas of technology, science, and patient care for cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Optimizing care for men with overactive bladder, with Keith Xavier, MD
4
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
5






